We observed no differences in these populations, suggesting that the increase in arthritis severity and in pro-inflammatory T cells was indeed due to a reduction of CD19+CD21hiCD24hiBregs rather than a consequence of abnormal B cell development (Figures 6A and 6B; Figures S5A–S5H). Here, CD19 is linked to arthritic joint disease.